retatrutide news today october 2025 This is exciting. π The TRIUMPH-4 trial results for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose groupβfar beyond New weight loss drug dubbed
Description
92 Luseogliflozin is a selective SGLT-2 inhibitor that received marketing approval on March 24, 2014, for the treatment of T2DM
The key is being honest about the tradeoffs
doi: 10.1056/NEJMoa1509225 62 FonsecaVAAlvarado-RuizRRaccahDBokaGMiossecPGerichJEet al
Weight regain can begin soon after discontinuation
& Silvestre, L
Elahi to refine goals
